Cargando…

TNF-α inhibitor therapy can improve the immune imbalance of CD4+ T cells and negative regulatory cells but not CD8+ T cells in ankylosing spondylitis

BACKGROUND: Studies into ankylosing spondylitis (AS) and its relationship with immune imbalance are controversial, and the correlation between the efficacy of TNF-α inhibitor and changes in immune imbalance is unclear. METHODS: A total of 40 immune cells were tested with flow cytometry, and the resu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Mingcan, Lv, Qing, Wei, Qiujing, Jiang, Yutong, Qi, Jun, Xiao, Min, Fang, Linkai, Xie, Ya, Cao, Shuangyan, Lin, Zhiming, Zhang, Yanli, Tu, Liudan, Zhao, Minjing, Pan, Yunfeng, Jin, Ou, Gu, Jieruo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7304211/ https://www.ncbi.nlm.nih.gov/pubmed/32560733 http://dx.doi.org/10.1186/s13075-020-02226-8

Ejemplares similares

Serum Metabolomics Signatures Associated With Ankylosing Spondylitis and TNF Inhibitor Therapy
por: Ou, Jiayong, et al.
Publicado: (2021)

Cost of Illness, Quality of Life, and Work Outcomes in Active Ankylosing Spondylitis Patients Treated With Adalimumab in China
por: Tu, Liudan, et al.
Publicado: (2020)

Dynamics of Adaptive Immune Cell and NK Cell Subsets in Patients With Ankylosing Spondylitis After IL-17A Inhibition by Secukinumab
por: Jiang, Yutong, et al.
Publicado: (2021)

Efficacy and safety of loxoprofen hydrogel patch versus loxoprofen tablet in patients with ankylosing spondylitis: A 4-week randomized, open-label study
por: Fan, Meida, et al.
Publicado: (2019)

Etanercept/celecoxib on improving MRI inflammation of active ankylosing spondylitis: A multicenter, open-label, randomized clinical trial
por: Tu, Liudan, et al.
Publicado: (2022)

The Clinical Characteristics of Other HLA-B Types in Chinese Ankylosing Spondylitis Patients
por: Wu, Xinyu, et al.
Publicado: (2021)

Circulating Retinol-Binding Protein 4 as a Possible Biomarker of Treatment Response for Ankylosing Spondylitis: An Array-Based Comparative Study
por: Wu, Jialing, et al.
Publicado: (2020)

Pain- and Fatigue-Related Functional and Structural Changes in Ankylosing Spondylitis: An fRMI Study
por: Liu, Qi, et al.
Publicado: (2020)

Complex Segregation Analysis Provides Evidence for Autosomal Dominant Transmission in the Chinese Han Families with Ankylosing Spondylitis
por: Jiang, Yutong, et al.
Publicado: (2017)

Disorders of MicroRNAs in Peripheral Blood Mononuclear Cells: As Novel Biomarkers of Ankylosing Spondylitis and Provocative Therapeutic Targets
por: Lv, Qing, et al.
Publicado: (2015)

Serum Vitamin D and Pyridinoline Cross-Linked Carboxyterminal Telopeptide of Type I Collagen in Patients with Ankylosing Spondylitis
por: Zhang, Pingping, et al.
Publicado: (2015)

Age-Specific Imbalance of Circulating Tfh Cell Subsets and Its Association With Gout-Targeted Kidney Impairment
por: Huang, Yefei, et al.
Publicado: (2021)

Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis
por: Chen, Zena, et al.
Publicado: (2021)

A Genome-Wide SNP Linkage Analysis Suggests a Susceptibility Locus on 6p21 for Ankylosing Spondylitis and Inflammatory Back Pain Trait
por: Zhang, Yanli, et al.
Publicado: (2016)

Spondyloarthritis Patients Suffer Increased Risk of Renal Complications Compared With General Population: A Retrospective Observational Study
por: Xiao, Min, et al.
Publicado: (2019)

Using Mobile Apps for Health Management: A New Health Care Mode in China
por: Lv, Qing, et al.
Publicado: (2019)

Imbalance of Peripheral Lymphocyte Subsets in Patients With Ankylosing Spondylitis: A Meta-Analysis
por: Liu, Dong, et al.
Publicado: (2021)

Integrative blood-derived epigenetic and transcriptomic analysis reveals the potential regulatory role of DNA methylation in ankylosing spondylitis
por: Xiao, Min, et al.
Publicado: (2022)

Clinical Features in Juvenile-Onset Ankylosing Spondylitis Patients Carrying Different B27 Subtypes
por: Mou, Yikun, et al.
Publicado: (2015)

Circulating cytotoxic CD8(+) CD28(-) T cells in ankylosing spondylitis
por: Schirmer, Michael, et al.
Publicado: (2002)

Ataxia-televangelist mutated (ATM)/ ATR serine/threonine kinase (ATR)-mediated RAD51 recombinase (RAD51) promotes osteogenic differentiation and inhibits osteoclastogenesis in osteoporosis
por: Qiu, Minli, et al.
Publicado: (2022)

Kunxian capsules in the treatment of patients with ankylosing spondylitis: a randomized placebo-controlled clinical trial
por: Li, Qiuxia, et al.
Publicado: (2016)

Age determines response to anti-TNFα treatment in patients with ankylosing spondylitis and is related to TNFα-producing CD8 cells
por: Schramm-Luc, Agata, et al.
Publicado: (2018)

Serum from patients with ankylosing spondylitis can increase PPARD, fra-1, MMP7, OPG and RANKL expression in MG63 cells
por: Hu, Zaiying, et al.
Publicado: (2015)

Enrichment of CD8+ CD28- cytotoxic T cells in circulating lymphocytes of patients with ankylosing spondylitis
por: Schirmer, M, et al.
Publicado: (2001)

CD96 Downregulation Promotes the Immune Response of CD4 T Cells and Associates with Ankylosing Spondylitis
por: Wu, Fengqing, et al.
Publicado: (2022)

T lymphocyte subset imbalances in patients contribute to ankylosing spondylitis
por: WANG, CHENGGONG, et al.
Publicado: (2015)

Prevalence, clinical relevance and characterization of circulating cytotoxic CD4(+)CD28(- )T cells in ankylosing spondylitis
por: Duftner, Christina, et al.
Publicado: (2003)

A Rare Co-Segregation-Mutation in the Insulin Receptor Substrate 1 Gene in One Chinese Family with Ankylosing Spondylitis
por: Rong, Ju, et al.
Publicado: (2015)

Anti-TNF-α Therapy for Ankylosing Spondylitis
por: Son, Jung-Hwan, et al.
Publicado: (2010)

Active Inflammatory and Chronic Structural Damages of Sacroiliac Joint in Patients With Radiographic Axial Spondyloarthritis and Non-Radiographic Axial Spondyloarthritis
por: Tu, Liudan, et al.
Publicado: (2021)

Functional defects in CD4(+) CD25(high) FoxP3(+) regulatory cells in ankylosing spondylitis
por: Guo, Huifang, et al.
Publicado: (2016)

Editorial: Advances in Pathogenesis, Etiology, and Therapies for Ankylosing Spondylitis
por: Chen, Chih-Wei, et al.
Publicado: (2021)

TNF-alpha antagonists for treatment of juvenile ankylosing spondylitis
por: Orbán, I, et al.
Publicado: (2011)

Decreased levels of T follicular helper (CD4+CXCR5+) cells and CD27+CD38+ and CD27+CD38− B cells in ankylosing spondylitis patients correlate with markers of inflammation
por: Lejon, Kristina, et al.
Publicado: (2022)

Analysis of antinuclear antibody titers and patterns by using HEp‐2 and primate liver tissue substrate indirect immunofluorescence assay in patients with systemic autoimmune rheumatic diseases
por: Wei, Qiujing, et al.
Publicado: (2020)

Ankylosing Spondylitis: From Cells to Genes
por: Zambrano-Zaragoza, José Francisco, et al.
Publicado: (2013)

Cytokines and regulatory T cells in ankylosing spondylitis
por: Liao, Hsien-Tzung, et al.
Publicado: (2023)

Immunogenetic Study in Chinese Population with Ankylosing Spondylitis: Are There Specific Genes Recently Disclosed?
por: Zhai, Jiayu, et al.
Publicado: (2013)

Imbalance between HAT and HDAC Activities in the PBMCs of Patients with Ankylosing Spondylitis or Rheumatoid Arthritis and Influence of HDAC Inhibitors on TNF Alpha Production
por: Toussirot, Eric, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ucutt6b0p6t794qrvmcp70uftt